rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Abbas Hussain

Director

Company insider

Files Form 4 as: Director, Moderna; Director, Mallinckrodt; Director, Teva Pharmaceutical Industries.

Every Form 4 they filed

In numbers

Trades disclosed
31
Buys
0
Sells
3
Bought
$0
Sold
$553K
Companies
3
Companies where not an officer
3
First trade
2 Sep 2020
Last trade
6 May 2026
Last filed
8 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MRNA ModernaDirector · Biotechnology · last 6 May 20260 buys · 3 sells
MallinckrodtDirector · last 31 Jul 20250 buys · 0 sells
TEVA Teva Pharmaceutical IndustriesDirector · Pharmaceuticals · last 14 Jun 20210 buys · 0 sells

Activity over time

1 Jun 2025 – 1 Oct 2026
10Jun 25Oct 25Feb 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
6 May 2026filed 8 May 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—8,371 at $0.00filing
6 May 2026filed 8 May 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—8,371 at $0.00filing
1 May 2026filed 4 May 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$265K5,682 at $46.63filing
1 May 2026filed 4 May 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$265K5,682 at $46.63filing
30 Apr 2026filed 4 May 2026MRNA ModernaBiotechnologySEC FORM 4 Code M—16,233filing
30 Apr 2026filed 4 May 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—16,233 at $0.00filing
30 Apr 2026filed 4 May 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—16,233 at $0.00filing
30 Apr 2026filed 4 May 2026MRNA ModernaBiotechnologySEC FORM 4 Code M—16,233filing
9 Dec 2025filed 11 Dec 2025MRNA ModernaBiotechnologySEC FORM 4 Sold$14K504 at $27.60filing
2 Oct 2025filed 6 Oct 2025MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—1,439 at $0.00filing
2 Oct 2025filed 6 Oct 2025MRNA ModernaBiotechnologySEC FORM 4 Code M—1,439filing
31 Jul 2025filed 4 Aug 2025Mallinckrodtoption or derivativeSEC FORM 4 Code A—16,414 at $0.00filing
31 Jul 2025filed 4 Aug 2025Mallinckrodtoption or derivativeSEC FORM 4 Code D—9,850filing
31 Jul 2025filed 4 Aug 2025Mallinckrodtoption or derivativeSEC FORM 4 Code M—12,036 at $0.00filing
31 Jul 2025filed 4 Aug 2025MallinckrodtSEC FORM 4 Code M—12,036filing
31 Jul 2025filed 4 Aug 2025MallinckrodtSEC FORM 4 Code F—3,433filing
11 Jun 2025filed 12 Jun 2025MRNA ModernaBiotechnologySEC FORM 4 Sold$8,736312 at $28.00filing
30 Apr 2025filed 1 May 2025MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—892 at $0.00filing
30 Apr 2025filed 1 May 2025MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—16,233 at $0.00filing
30 Apr 2025filed 1 May 2025MRNA ModernaBiotechnologySEC FORM 4 Code M—892filing

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Stephen HogePresident · President at Moderna, filing Form 4 there in the last year
James M. MockChief Financial Officer · Chief Financial Officer at Moderna, filing Form 4 there in the last year
Shannon Thyme KlingerChief Legal Officer · Chief Legal Officer at Moderna, filing Form 4 there in the last year
Stephane BancelChief Executive Officer · Chief Executive Officer at Moderna, filing Form 4 there in the last year
Michael R. McDonnellDirector · Director at Moderna, filing Form 4 there in the last year
Maria Elvira SalazarRepresentative, FL-27 · Also traded MRNA in the last 90 days
Donald J. TrumpPresident · Also traded MRNA in the last 90 days